Diagnosis and treatment of diabetes mellitus in chronic pancreatitis

World Journal of Gastroenterology

Volumn 19, Issue 42, 2013, Pages 7276-7281

  Ewald, Nils ^a,b   Hardt, Philip D ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b General Hospital Luebbecke Rahden   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Chronic pancreatitis; Diabetes mellitus; Pancreatitis; Pancreatogenic diabetes; Type 3c diabetes

Indexed keywords

C PEPTIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN; METFORMIN; SULFONYLUREA; THIAZOLIDINE DERIVATIVE;

ABDOMINAL DISCOMFORT; ARTICLE; CHRONIC PANCREATITIS; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; FLUID RETENTION; FRACTURE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; LIPID HYDROLYSIS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS EXOCRINE INSUFFICIENCY; PREVALENCE; SIDE EFFECT; STEATORRHEA; STOMACH EMPTYING; TYPE 3C DIABETES MELLITUS; VITAMIN D DEFICIENCY; WEIGHT REDUCTION;

CHRONIC PANCREATITIS; DIABETES MELLITUS; PANCREATITIS; PANCREATOGENIC DIABETES; TYPE 3C DIABETES;

COMBINED MODALITY THERAPY; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC ERRORS; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; MALNUTRITION; PANCREATITIS, CHRONIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84887589758     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i42.7276     Document Type: Article

References (46)

1. Wang W, Guo Y, Liao Z, Zou DW, Jin ZD, Zou DJ, Jin G, Hu XG, Li ZS. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas 2011; 40: 206-212 [PMID: 21404458 DOI: 10.1097/ MPA.0b013e31820032ae]
2. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Lévy P. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000; 119: 1324-1332 [PMID: 11054391 DOI: 10.1053/ gast.2000.19286]
3. Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia 1980; 19: 198-204 [PMID: 6997121]
4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1: S5-S20 [PMID: 12502614 DOI: 10.2337/diacare. 26.2007.S5]
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 Suppl 1: S62-S69 [PMID: 21193628 DOI: 10.2337/dc11-S062]
6. Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care 2008; 31 Suppl 2: S165-S169 [PMID: 18227480 DOI: 10.2337/dc08-s244]
7. Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev 2012; 28: 338-342 [PMID: 22121010 DOI: 10.1002/dmrr.2260]
8. Ganda O. Secondary forms of diabetes. In: Kahn CR, Weir GC (editors). Joslin's Diabetes Mellitus. New York: Lea & Febiger, 1994
9. Alberti KGMM. Diabetes secondary to pancreatopathy: an example of brittle diabetes. In: Tiengo A, Alberti KGMM, Del Prato S, Vranic M (editors). Diabetes Secondary to Pancreatopathy. Proceedings of the Post EASD International Symposium on Diabetes Secondary to Pancreatopathy, Padova, 21-22 September 1987, International Congress Series 762. Amsterdam: Excerpta Medica, 1988: 211-214
10. Abu-Bakare A, Taylor R, Gill GV, Alberti KG. Tropical or malnutrition-related diabetes: a real syndrome? Lancet 1986; 1: 1135-1138 [PMID: 2871387 DOI: 10.1016/ S0140-6736(86)91846-5]
11. Mohan V, Pitchumoni C. Tropical chronic pancreatitis. In: Beger HG, Warshaw AL, Buechler MW, Carr-Locke DL, Neoptolemos JP, Russel C, Sarr MG (editors). The Pancreas. London: Blackwell Science, 1998: 688-697
12. Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology 2011; 11: 279-294 [PMID: 21757968 DOI: 10.1159/000329188]
13. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707 [PMID: 11179244 DOI: 10.1053/ gast.2001.22586]
14. Doerr W. Pathogenesis of acute and chronic pancreatitis. Verh Dtsch Ges Inn Med 1964; 70: 718-758 [PMID: 14298752 DOI: 10.1007/978-3-642-96030-7_116]
15. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 1978; 86A: 367-373 [PMID: 716899 DOI: 10.1111/ j.1699-0463.1978.tb02058.x]
16. Blumenthal HT, Probstein JG, Berns AW. Interrelationship of diabetes mellitus and pancreatitis. Arch Surg 1963; 87: 844-850 [PMID: 14058852 DOI: 10.1001/archsurg. 1963.01310170130022]
17. Petrone MC, Arcidiacono PG, Perri F, Carrara S, Boemo C, Testoni PA. Chronic pancreatitis-like changes detected by endoscopic ultrasound in subjects without signs of pancreatic disease: do these indicate age-related changes, effects of xenobiotics, or early chronic pancreatitis? Pancreatology 2010; 10: 597-602 [PMID: 20980777 DOI: 10.1159/000314599]
18. Rothenbacher D, Löw M, Hardt PD, Klör HU, Ziegler H, Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population- based study. Scand J Gastroenterol 2005; 40: 697-704 [PMID: 16036530 DOI: 10.1080/00365520510023116]
19. Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Le Maréchal C, Hentic O, Maire F, Hammel P, Ruszniewski P, Lévy P. The natural history of hereditary pancreatitis: a national series. Gut 2009; 58: 97-103 [PMID: 18755888 DOI: 10.1136/gut.2008.149179]
20. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004; 2: 252-261 [PMID: 15017610 DOI: 10.1016/S1542-3565(04)00013-8]
21. Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology 2013; 13: 336-342 [PMID: 23890130 DOI: 10.1016/j.pan.2013.05.002]
22. Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease? Eur J Intern Med 2013; 24: 203-206 [PMID: 23375619 DOI: 10.1016/j.ejim.2012.12.017]
23. Hardt PD, Krauss A, Bretz L, Porsch-Ozcürümez M, Schnell- Kretschmer H, Mäser E, Bretzel RG, Zekhorn T, Klör HU. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000; 37: 105-110 [PMID: 11277309 DOI: 10.1007/s005920070011]
24. Noel RA, Braun DK, Patterson RE, Bloomgren GL. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care 2009; 32: 834-838 [PMID: 19208917 DOI: 10.2337/ dc08-1755]
25. Moriai T, Morita Y, Matsui T, Okada M. Type 1 diabetes mellitus associated with clinical acute pancreatitis in an adult. Pancreas 2000; 20: 415-416 [PMID: 10824699 DOI: 10.10 97/00006676-200005000-00014]
26. Larsen S, Hilsted J, Tronier B, Worning H. Pancreatic hormone secretion in chronic pancreatitis without residual betacell function. Acta Endocrinol (Copenh) 1988; 118: 357-364 [PMID: 2899369 DOI: 10.1530/acta.0.1180357]
27. Valenzuela JE, Taylor IL, Walsh JH. Pancreatic polypeptide response in patients with chronic pancreatitis. Dig Dis Sci 1979; 24: 862-864 [PMID: 520107 DOI: 10.1007/BF01324903]
28. Glaser B, Zoghlin G, Pienta K, Vinik AI. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. Horm Metab Res 1988; 20: 288-292 [PMID: 3042579 DOI: 10.1055/s-2007-1010817]
29. Larsen S. Diabetes mellitus secondary to chronic pancreatitis. Dan Med Bull 1993; 40: 153-162 [PMID: 8495594]
30. Larsen S, Hilsted J, Tronier B, Worning H. Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. Metabolism 1987; 36: 964-967 [PMID: 3309547]
31. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 1986; 35: 530-545 [PMID: 2869996 DOI: 10.2337/diabetes.35.5.530]
32. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991; 34: 877-890 [PMID: 1778353 DOI: 10.1007/BF00400195]
33. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203 [PMID: 18945920 DOI: 10.2337/dc08-9025]
34. Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 2012; 18: 2905-2912 [PMID: 22465831 DOI: 10.1158/1078-0432. CCR-11-2994]
35. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andrén-Sandberg A, Domellöf L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437 [PMID: 8479461 DOI: 10.1056/ NEJM199305203282001]
36. Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken or egg? Pancreas 2011; 40: 339-351 [PMID: 21412116 DOI: 10.1097/MPA.0b013e318209e05d]
37. Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 2012; 23: 2964-2970 [PMID: 22767586 DOI: 10.1093/annonc/ mds140]
38. Alves C, Batel-Marques F, Macedo AF. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer. Diabetes Res Clin Pract 2012; 98: 271-284 [PMID: 23010561 DOI: 10.1016/ j.diabres.2012.09.008]
39. Klapdor S, Richter E, Klapdor R. Vitamin D status and peroral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res 2012; 32: 1991-1998 [PMID: 22593477]
40. Sikkens EC, Cahen DL, Koch AD, Braat H, Poley JW, Kuipers EJ, Bruno MJ. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology 2013; 13: 238-242 [PMID: 23719594 DOI: 10.1016/j.pan.2013.02.008]
41. Mann ST, Mann V, Stracke H, Lange U, Klör HU, Hardt P, Teichmann J. Fecal elastase 1 and vitamin D3 in patients with osteoporotic bone fractures. Eur J Med Res 2008; 13: 68-72 [PMID: 18424365]
42. Teichmann J, Mann ST, Stracke H, Lange U, Hardt PD, Klör HU, Bretzel RG. Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis. Eur J Med Res 2007; 12: 347-350 [PMID: 17933711]
43. Ford ES, Zhao G, Tsai J, Li C. Associations between concentrations of vitamin D and concentrations of insulin, glucose, and HbA1c among adolescents in the United States. Diabetes Care 2011; 34: 646-648 [PMID: 21273498 DOI: 10.2337/ dc10-1754]
44. Boucher BJ. Vitamin D insufficiency and diabetes risks. Curr Drug Targets 2011; 12: 61-87 [PMID: 20795936 DOI: 10.2174/1 38945011793591653]
45. Beglinger S, Drewe J, Schirra J, Göke B, D'Amato M, Beglinger C. Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion. J Clin Endocrinol Metab 2010; 95: 879-886 [PMID: 19837920 DOI: 10.1210/jc.2009-1062]
46. Kuo P, Stevens JE, Russo A, Maddox A, Wishart JM, Jones KL, Greville H, Hetzel D, Chapman I, Horowitz M, Rayner CK. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation. J Clin Endocrinol Metab 2011; 96: E851-E855 [PMID: 21389144 DOI: 10.1210/jc.2010-2460]